System for non-invasive prenatal diagnostics

Analyzing fetal DNA from the mother’s blood enables a non-invasive diagnosis of the unborn child.

As part of the EU project ANGELab, a lab-on-a-chip system for non-invasive prenatal in-vitro diagnostics (NIPD) was developed to detect genetic diseases. Non-invasive methods are easier on the mother and the unborn child, since they do not encroach on the body.

Precise diagnostics using digital PCR

Methods have been established by an international consortium that are able to isolate fetal DNA from the mother's blood. Hahn-Schickard has developed a method for the detection of various genetic traits, allowing for a precise analysis of such a sample. The detection reaction takes place through digital PCR, which allows for the performance of sensitive and quantitative diagnostics.

Your partner for the development of innovative test systems

Are you looking for a method that will allow you to precisely analyze your sample and would you like to become more familiar with our system? Then get in touch with us. We like to cooperate with new partners and can help you develop and apply new test systems.

You might also be interested in: